Fair post.Trying to get past the psychology of how, from a...

Fair post.

Trying to get past the psychology of how, from a shareholder value perspective, this has been a cluster#### to date. The change in management and clearly a lot going on in the background is all very positive, but the question is whether HMD has missed its opportunity. We are all probably so far in the hole now, it's not worth selling, even if you could. Best we can hope for is that tie ups occur and the platform is useful but we will get bought out at a price much higher than we are now but likely to be well below where we once were.

Current management is going to have to kick some serious goals to earn the faith of long term diehards though.

This is another example of why, in the past year, I have slowly been moving towards US stocks where liquidity and valuations make investing and trading so much easier. There is just too much going on in the US biotech and healthcare sectors, where there are massive financial incentives for disruption given how bad their healthcare system is